LADENBURG THALMANN FINANCIAL SERVICES INC. - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 36 filers reported holding CARDIOME PHARMA CORP in Q4 2015. The put-call ratio across all filers is 18.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q4 2015$20,000
-4.8%
2,5000.0%0.00%
Q3 2015$21,000
-12.5%
2,5000.0%0.00%
Q2 2015$24,000
+4.3%
2,5000.0%0.00%
Q1 2015$23,0000.0%2,5000.0%0.00%
-100.0%
Q4 2014$23,000
+4.5%
2,5000.0%0.00%0.0%
Q3 2014$22,000
+10.0%
2,5000.0%0.00%0.0%
Q2 2014$20,0000.0%2,5000.0%0.00%0.0%
Q1 2014$20,000
+233.3%
2,500
+150.0%
0.00%
Q4 2013$6,0001,0000.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,195,692$4,953,0002.97%
Tamarack Advisers, LP 1,875,000$2,906,0001.59%
CLOUGH CAPITAL PARTNERS L P 2,667,585$4,135,0000.34%
Rock Springs Capital Management LP 1,200,000$1,860,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,678,364$7,251,0000.06%
KNOTT DAVID M 67,978$105,0000.04%
PUTNAM INVESTMENTS LLC 6,184,266$9,586,0000.01%
AlphaOne Investment Services, LLC 10,625$16,0000.01%
A.R.T. Advisors, LLC 34,872$54,0000.00%
Virtu Financial LLC 11,693$18,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders